Yantai Zhenghai Biotechnology Co., Ltd.

XSEC:300653 Stock Report

Market Cap: CN¥3.5b

Yantai Zhenghai Biotechnology Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Kan Song

Chief executive officer

CN¥1.1m

Total compensation

CEO salary percentagen/a
CEO tenure2.4yrs
CEO ownershipn/a
Management average tenure5.1yrs
Board average tenure5.7yrs

Recent management updates

Recent updates

CEO

Kan Song (41 yo)

2.4yrs

Tenure

CN¥1,116,100

Compensation

Mr. Kan Song is Chairman since April 12, 2023 & General Manager and Director of Yantai Zhenghai Biotechnology Co., Ltd. from January 06, 2023. He is Secretary of Yantai Zhenghai Biotechnology Co., Ltd sinc...

Leadership Team

NamePositionTenureCompensationOwnership
Kan Song
GM, Secretary & Chairman2.4yrsCN¥1.12mno data
Li Zhao
Deputy GMno dataCN¥904.90kno data
Xing Yang
Deputy General Manager5.1yrsCN¥1.52mno data
Donggang Zhang
Deputy General Manager7.8yrsCN¥907.90kno data

5.1yrs

Average Tenure

46.5yo

Average Age

Experienced Management: 300653's management team is seasoned and experienced (5.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kan Song
GM, Secretary & Chairman2.3yrsCN¥1.12mno data
Li Zhao
Deputy GM5yrsCN¥904.90kno data
Dong Qun
Vice Chairman9.9yrsno datano data
Chao Zhang
Non-Independent Director7.1yrsno datano data
Weiguo Jiang
Non-Independent Director5.7yrsno datano data
Hui Xu
Independent Director4.1yrsCN¥60.00kno data
Xiliang Song
Independent Director4.1yrsCN¥60.00kno data
Landing Zhang
Independent Director4.1yrsCN¥60.00kno data
Yueli Xu
Chairman of the Supervisory Board9.9yrsno datano data
Lishan Pan
Non-Employee Supervisor5.7yrsno datano data
Lei Zhao
Employee Supervisor9.9yrsno datano data

5.7yrs

Average Tenure

49yo

Average Age

Experienced Board: 300653's board of directors are considered experienced (5.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 17:38
End of Day Share Price 2025/05/16 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Yantai Zhenghai Biotechnology Co., Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yanyin ZhuChina International Capital Corporation Limited
Bin WuChina Merchants Securities Co. Ltd.
Wen DaiHuatai Research